Smith and Nephew exports low-tech manufacturing as setbacks mount
This article was originally published in Clinica
Smith & Nephew, the UK-based orthopaedics and woundcare company, has begun to move some of its low-tech manufacturing out of its high-cost bases to reduce costs.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.